Related references
Note: Only part of the references are listed.Utility of PAX8 and PAX2 immunohistochemistry in the identification of renal cell carcinoma in diagnostic cytology
Stewart M. Knoepp et al.
DIAGNOSTIC CYTOPATHOLOGY (2012)
Cluster analysis of immunohistochemical profiles delineates CK7, vimentin, S100A1 and C-kit (CD117) as an optimal panel in the differential diagnosis of renal oncocytoma from its mimics
Jason C. Carvalho et al.
HISTOPATHOLOGY (2011)
PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study
Ayhan Ozcan et al.
MODERN PATHOLOGY (2011)
PAX8 (+)/p63 (-) Immunostaining Pattern in Renal Collecting Duct Carcinoma (CDC) A Useful Immunoprofile in the Differential Diagnosis of CDC Versus Urothelial Carcinoma of Upper Urinary Tract
Roula Albadine et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Diagnostic Implications of Transcription Factor Pax 2 Protein and Transmembrane Enzyme Complex Carbonic Anhydrase IX Immunoreactivity in Adult Renal Epithelial Neoplasms
Ruta Gupta et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
Expression of PAX8 in normal and neoplastic renal tissues: an immunohistochemical study
Guo-Xia Tong et al.
MODERN PATHOLOGY (2009)
Neoplasms of the upper urinary tract - A review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting
Ruta Gupta et al.
ADVANCES IN ANATOMIC PATHOLOGY (2008)
Collecting duct carcinoma of the kidney: an immunohistochemical evaluation of the use of antibodies for differential diagnosis
Naohito Kobayashi et al.
HUMAN PATHOLOGY (2008)
Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior
Jason X. Cheng et al.
MODERN PATHOLOGY (2008)
Diagnostic utility of S100A1 expression in renal cell neoplasms:: an immunohistochemical and quantitative RT-PCR study
Paolo Cossu Rocca et al.
MODERN PATHOLOGY (2007)
Collecting duct (Bellini duct) renal cell carcinoma: A nationwide survey in Japan
Noriaki Tokuda et al.
JOURNAL OF UROLOGY (2006)
Alpha-methyl CoA racemase expression in renal cell carcinomas
V Molinié et al.
HUMAN PATHOLOGY (2006)
Prostate-specific antigen, high-molecular-weight cytokeratin (Clone 34βE12), and/or p63 -: An optimal lmmunohistochemical panel to distinguish poorly differentiated prostate adenocarcinoma from urothelial carcinoma
LP Kunju et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2006)
Expression of alpha-methylacyl-CoA racemase in papillary renal cell carcinoma
MS Tretiakova et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
P63 immunoreactivity distinguishes upper urinary tract transitional-cell carcinoma and renal-cell carcinoma even in poorly differentiated tumors
C Langner et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2003)
Share Paper
